Longitudinal study of the development of osteoarthritis and musculoskeletal disability in 961 individuals aged 50-72 is currently in its seventh year. Initial cross-sectional and two-year longitudinal data have been reported, and five-year data are being analyzed at present. This project extends the study an additional five years, entering the study phase where initial hypotheses may be addressed more definitively. The proposed study consists of six sub-projects. First, continued execution of data acquisition protocols including close follow-up and high retention rates in the study over time and reliability and validity studies. These data will provide the substrate for the remaining sub- projects. Second, analysis of the rate of development of musculoskeletal disability and the variables which are the best predictors of accelerated musculoskeletal disability in a community population. Third, analysis of the rate and best predictors of development of radiologic osteoarthritis in a smaller intensively studied group. Fourth, a seven and ten year comparison of the development of musculoskeletal disability in runners and non-runners. Fifth, an eight-and eleven-year study of the development of radiologic osteoarthritis comparing runners and non- runners in an intensive study group. Sixth, studies of the rate of development of osteopenia and the factors which affect this rate.

Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
1996
Total Cost
Indirect Cost
Ward, M M; Marx, A S; Barry, N N (2002) Psychological distress and changes in the activity of systemic lupus erythematosus. Rheumatology (Oxford) 41:184-8
Lubeck, D P (2001) A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings. Pharmacoeconomics 19:811-8
Ward, M M; Marx, A S; Barry, N N (2000) Identification of clinically important changes in health status using receiver operating characteristic curves. J Clin Epidemiol 53:279-84
Ward, M M; Marx, A S; Barry, N N (2000) The rating scale preference measure as an evaluative measure in systemic lupus erythematosus. Lupus 9:696-701
Ward, M M; Marx, A S; Barry, N N (2000) Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 27:664-70
Calkins, H; Yong, P; Miller, J M et al. (1999) Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 99:262-70
Fischer, D; Stewart, A L; Bloch, D A et al. (1999) Capturing the patient's view of change as a clinical outcome measure. JAMA 282:1157-62
van Vollenhoven, R F; Park, J L; Genovese, M C et al. (1999) A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus 8:181-7
Ward, M M; Lubeck, D; Leigh, J P (1998) Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings. J Rheumatol 25:641-9
Hsieh, F Y; Bloch, D A; Larsen, M D (1998) A simple method of sample size calculation for linear and logistic regression. Stat Med 17:1623-34

Showing the most recent 10 out of 47 publications